These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 27000123)

  • 41. HIV and viral hepatitis C coinfection in people who inject drugs: implications of new direct acting antivirals for hepatitis C virus treatment.
    Walsh N; Maher L
    Curr Opin HIV AIDS; 2012 Jul; 7(4):339-44. PubMed ID: 22498482
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Recombination in hepatitis C virus is not uncommon among people who inject drugs in Kolkata, India.
    Gupta D; Saha K; Biswas A; Firdaus R; Ghosh M; Sadhukhan PC
    Infect Genet Evol; 2017 Mar; 48():156-163. PubMed ID: 27923769
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Higher risk of incident hepatitis C virus coinfection among men who have sex with men, in whom the HIV genetic bottleneck at transmission was wide.
    Kouyos RD; Rauch A; Braun DL; Yang WL; Böni J; Yerly S; Klimkait T; Aubert V; Shah C; Kovari H; Calmy A; Cavassini M; Battegay M; Vernazza PL; Bernasconi E; Ledergerber B; Günthard HF;
    J Infect Dis; 2014 Nov; 210(10):1555-61. PubMed ID: 24943723
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Hepatitis B and C virus coinfection in The TREAT Asia HIV Observational Database.
    Zhou J; Dore GJ; Zhang F; Lim PL; Chen YM;
    J Gastroenterol Hepatol; 2007 Sep; 22(9):1510-8. PubMed ID: 17645479
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Medical management of HIV-hepatitis C virus coinfection in injection drug users.
    Khalsa JH; Kresina T; Sherman K; Vocci F
    Clin Infect Dis; 2005 Jul; 41 Suppl 1():S1-6. PubMed ID: 16265605
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Management of HIV and hepatitis C virus infections in resource-limited settings.
    Ocama P; Seremba E
    Curr Opin HIV AIDS; 2011 Nov; 6(6):539-45. PubMed ID: 21918435
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prevalence of HIV, hepatitis C and syphilis among injecting drug users in Russia: a multi-city study.
    Rhodes T; Platt L; Maximova S; Koshkina E; Latishevskaya N; Hickman M; Renton A; Bobrova N; McDonald T; Parry JV
    Addiction; 2006 Feb; 101(2):252-66. PubMed ID: 16445554
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Substance Abuse and the HIV Situation in Malaysia.
    Singh D; Chawarski MC; Schottenfeld R; Vicknasingam B
    J Food Drug Anal; 2013 Dec; 21(4):S46-S51. PubMed ID: 25278737
    [TBL] [Abstract][Full Text] [Related]  

  • 49. HIV/HCV Co-infection: Burden of Disease and Care Strategies in Appalachia.
    Moorman JP; Krolikowski MR; Mathis SM; Pack RP
    Curr HIV/AIDS Rep; 2018 Aug; 15(4):308-314. PubMed ID: 29931466
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Promoting Global Health - Prevention and Treatment of Substance Abuse and HIV in Asia.
    Li MD; Hser YI; Chen Z; Chang L
    J Neuroimmune Pharmacol; 2016 Sep; 11(3):379-82. PubMed ID: 27484319
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Compulsory treatment of drug use in Southeast Asian countries.
    Lunze K; Lermet O; Andreeva V; Hariga F
    Int J Drug Policy; 2018 Sep; 59():10-15. PubMed ID: 29966803
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Understanding Vietnam's drug policy for amphetamine-type stimulants misuse.
    Tran MTN; Dunne MP; Minh Le G; Han HD; Nguyen TT; Luong HT; Luong QH; Pham HN; Baker P
    Harm Reduct J; 2022 May; 19(1):45. PubMed ID: 35562829
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Medical consequences of drug abuse and co-occurring infections: research at the National Institute on Drug Abuse.
    Khalsa JH; Treisman G; McCance-Katz E; Tedaldi E
    Subst Abus; 2008; 29(3):5-16. PubMed ID: 19042203
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Substance use disorders and HIV in Vietnam since
    Giang LM; Ngoc LB; Hoang VH; Mulvey K; Rawson RA
    J Food Drug Anal; 2013 Dec; 21(4):S42-S45. PubMed ID: 25278736
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Recreational drug use in the Asia Pacific region: improvement in our understanding of the problem through the UNODC programmes.
    Dargan PI; Wood DM
    J Med Toxicol; 2012 Sep; 8(3):295-9. PubMed ID: 22569822
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Treatment for drug dependence.
    Des Jarlais DC; Hubbard R
    Proc Assoc Am Physicians; 1999; 111(2):126-30. PubMed ID: 10220807
    [TBL] [Abstract][Full Text] [Related]  

  • 57. HIV and people who use drugs in central Asia: confronting the perfect storm.
    El-Bassel N; Strathdee SA; El Sadr WM
    Drug Alcohol Depend; 2013 Nov; 132 Suppl 1(0 1):S2-6. PubMed ID: 23953656
    [No Abstract]   [Full Text] [Related]  

  • 58. Capacity building and collaborative research on cross-national studies in the Asian region.
    Hser YI; Chang L; Wang GJ; Li MD; Rawson R; Shoptaw S; Normand J; Tai B
    J Food Drug Anal; 2013 Dec; 21(4):S117-S122. PubMed ID: 24567700
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Use and abuse of amphetamine-type stimulants in the United States of America.
    Cajetan Luna G
    Rev Panam Salud Publica; 2001 Feb; 9(2):114-22. PubMed ID: 11293829
    [No Abstract]   [Full Text] [Related]  

  • 60. The relevance of social epidemiology in HIV/AIDS and drug abuse research.
    Rothenberg R
    Am J Prev Med; 2007 Jun; 32(6 Suppl):S147-53. PubMed ID: 17543705
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.